Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 4:29 pm Purchase | 13G | KINTARA THERAPEUTICS INC N KTRA | Lind Global Fund II LP | 75,472 0.1% | 75,472 (New Position) | View |
| 2022-04-20 5:11 pm Purchase | 13G | KINTARA THERAPEUTICS INC KTRA | Lind Global Fund II LP | 3,773,586 5.8% | 3,773,586 (New Position) | View |
| 2022-02-07 1:26 pm Sale | 13G | KINTARA THERAPEUTICS INC KTRA | Pilkiewicz Carolyn | 1,170,290 2.41% | -562,499 (-32.46%) | View |
| 2021-02-08 3:18 pm Sale | 13G | KINTARA THERAPEUTICS INC KTRA | Pilkiewicz Carolyn | 1,732,789 7.03% | -525,000 (-23.25%) | View |
| 2021-01-29 07:00 am Purchase | 13G | KINTARA THERAPEUTICS INC KTRA | INTRACOASTAL CAPITAL LLC | 900,125 3.5% | 900,125 (New Position) | View |
| 2020-11-16 2:37 pm Purchase | 13G | KINTARA THERAPEUTICS INC KTRA | Pilkiewicz Carolyn | 2,257,789 9.15% | 2,257,789 (New Position) | View |
| 2020-08-28 4:05 pm Purchase | 13G | KINTARA THERAPEUTICS INC KTRA | STERN ADAM K | 1,653,970 6.95% | 1,653,970 (New Position) | View |
| 2020-02-14 3:56 pm Sale | 13G | DELMAR PHARMACEUTICALS INC DMPI | Anson Funds Management LP | 290,125 1.5% | -4,875 (-1.65%) | View |
| 2020-02-11 06:19 am Sale | 13G | DELMAR PHARMACEUTICALS INC DMPI | INTRACOASTAL CAPITAL LLC | 700,000 5.8% | -208,021 (-22.91%) | View |
| 2020-02-10 3:16 pm Sale | 13G | DELMAR PHARMACEUTICALS INC DMPI | CVI Investments Inc. | 599,131 4.9% | -75,869 (-11.24%) | View |
| 2020-01-23 3:10 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | Empery Asset Management LP | 1,440,125 4.99% | 1,147,625 (+392.35%) | View |
| 2020-01-21 12:17 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | SABBY MANAGEMENT LLC | 568,845 11% | 568,845 (New Position) | View |
| 2019-08-23 5:11 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | INTRACOASTAL CAPITAL LLC | 908,021 9.99% | 709,777 (+358.03%) | View |
| 2019-08-23 09:59 am Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | CVI Investments Inc. | 675,000 8.5% | 675,000 (New Position) | View |
| 2019-06-13 4:08 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | Anson Funds Management LP | 295,000 7.7% | 295,000 (New Position) | View |
| 2019-06-12 5:24 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | INTRACOASTAL CAPITAL LLC | 198,244 4.99% | 198,244 (New Position) | View |
| 2019-06-05 2:19 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | Empery Asset Management LP | 292,500 7.65% | 292,500 (New Position) | View |